Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
School of Nursing, Columbia University, New York, NY.
Am J Infect Control. 2019 Jul;47(7):750-754. doi: 10.1016/j.ajic.2018.12.021. Epub 2019 Feb 5.
This study aimed to examine the association between colonizing respiratory tract organism and frequency, duration, and time between subsequent hospitalizations among hospitalized patients with cystic fibrosis (CF).
This retrospective cohort study of 312 CF patients from 2 New York City hospitals (2006-2016) examined the effects of colonization with Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant S aureus (MRSA), co-colonization on incidence of hospitalization, time to next hospitalization, and total length of stay (LOS).
Annual rate of subsequent hospitalizations was highest in patients with P aeruginosa: adjusted incidence rate ratios (aIRRs) were 2.75 (95% confidence interval [CI], 1.72-4.41) for P aeruginosa versus MSSA, 2.57 (95% CI, 1.52-4.31) for co-colonization versus MSSA, and 1.77 (95% CI, 1.04-3.01) for P aeruginosa versus MRSA. Time to readmission was shortest for P aeruginosa: aIRRs were 1.75 (95% CI, 1.05-2.94) for MRSA versus P aeruginosa, 1.64 (95% CI, 1.03-2.59) for MSSA versus P aeruginosa, and 1.61 (95% CI, 1.04-2.47) for co-colonization versus P aeruginosa. LOS was longest for P aeruginosa: aIRRs were 3.41 (95% CI, 2.19-5.32) for P aeruginosa versus MSSA, 1.66 (95% CI, 1.01-2.75) for co-colonization versus MSSA, 2.50 (95% CI, 1.58-3.93) for P aeruginosa versus MRSA, and 2.05 (95% CI, 1.32-3.18) for P aeruginosa versus co-colonization.
CF patients with P aeruginosa alone experienced more hospitalizations, longer LOS, and shorter time to readmission versus patients with S aureus or both organisms.
本研究旨在探讨定植于呼吸道的微生物与囊性纤维化(CF)住院患者的住院频率、住院时间以及两次住院之间的时间间隔之间的相关性。
这是一项回顾性队列研究,纳入了来自纽约市 2 家医院的 312 名 CF 患者(2006-2016 年),研究分析了铜绿假单胞菌、耐甲氧西林金黄色葡萄球菌(MSSA)或耐甲氧西林金黄色葡萄球菌(MRSA)定植以及合并定植对住院、下一次住院时间和总住院时间(LOS)的影响。
铜绿假单胞菌定植患者的后续住院年发生率最高:与 MSSA 相比,铜绿假单胞菌的校正发病率比(aIRR)分别为 2.75(95%可信区间[CI],1.72-4.41)、合并定植为 2.57(95% CI,1.52-4.31)、铜绿假单胞菌为 1.77(95% CI,1.04-3.01)。铜绿假单胞菌患者的再入院时间最短:与铜绿假单胞菌相比,MRSA 的 aIRR 为 1.75(95% CI,1.05-2.94)、MSSA 为 1.64(95% CI,1.03-2.59)、合并定植为 1.61(95% CI,1.04-2.47)。铜绿假单胞菌患者的 LOS 最长:与 MSSA 相比,铜绿假单胞菌的 aIRR 为 3.41(95% CI,2.19-5.32)、合并定植为 1.66(95% CI,1.01-2.75)、铜绿假单胞菌为 2.50(95% CI,1.58-3.93)、合并定植为 2.05(95% CI,1.32-3.18)。
与金黄色葡萄球菌或两种病原体定植的患者相比,单纯铜绿假单胞菌定植的 CF 患者住院次数更多、LOS 更长、再入院时间更短。